Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model

BACKGROUND: Urosepsis caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is increasing worldwide. Carbapenems are commonly recommended for the treatment of ESBL infections; however, to minimize the emergence of carbapenem resistance, interest in alternative treatments has heig...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Kamrul, Sime, Fekade B, Wallis, Steven C, Bauer, Michelle J, Forde, Brian M, Harris, Patrick, Shirin, Tahmina, Habib, Zakir H, Flora, Meerjady S, Roberts, Jason A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410668/
https://www.ncbi.nlm.nih.gov/pubmed/35724128
http://dx.doi.org/10.1093/jac/dkac186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410668/
https://www.ncbi.nlm.nih.gov/pubmed/35724128
http://dx.doi.org/10.1093/jac/dkac186

Ejemplares similares